These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12052673)

  • 1. Genetic susceptibility to environmental toxicants: the interface between human and experimental studies in the development of new toxicological concepts.
    Thier R; Golka K; Brüning T; Ko Y; Bolt HM
    Toxicol Lett; 2002 Feb; 127(1-3):321-7. PubMed ID: 12052673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic variations in the metabolism of environmental toxins].
    Autrup H
    Ugeskr Laeger; 2005 May; 167(20):2173-6. PubMed ID: 15987077
    [No Abstract]   [Full Text] [Related]  

  • 3. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms and metabolism of endocrine disruptors in cancer susceptibility.
    Hatagima A
    Cad Saude Publica; 2002; 18(2):357-77. PubMed ID: 11923879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of renal carcinoma: the nutri-genetic approach].
    Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
    J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variability in susceptibility and response to toxicants.
    Miller MC; Mohrenweiser HW; Bell DA
    Toxicol Lett; 2001 Mar; 120(1-3):269-80. PubMed ID: 11323185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of individual susceptibility in cancer burden related to environmental exposure.
    Bartsch H; Hietanen E
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of epidemiological studies on genetic susceptibility to environmental toxicants.
    Taioli E
    Toxicol Lett; 2002 Feb; 127(1-3):315-9. PubMed ID: 12052672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response.
    Autrup H
    Mutat Res; 2000 Jan; 464(1):65-76. PubMed ID: 10633178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
    Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
    Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism and their contribution to cancer susceptibility.
    Conforti-Froes N; el-Zein R; Au W
    Cad Saude Publica; 1998; 14 Suppl 3():7-13. PubMed ID: 9819460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic polymorphisms in xenobiotic metabolizing enzymes as a determinant of susceptibility to environmental mutagens and carcinogens in humans].
    Ozawa S
    Yakugaku Zasshi; 1997 Nov; 117(10-11):895-909. PubMed ID: 9414599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals.
    Nakajima T; Aoyama T
    Ind Health; 2000 Apr; 38(2):143-52. PubMed ID: 10812837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility--a review.
    Raunio H; Husgafvel-Pursiainen K; Anttila S; Hietanen E; Hirvonen A; Pelkonen O
    Gene; 1995 Jun; 159(1):113-21. PubMed ID: 7607565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variability in susceptibility and response to toxicants.
    Ingelman-Sundberg M
    Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma: etiology, incidence and epidemiology.
    Murai M; Oya M
    Curr Opin Urol; 2004 Jul; 14(4):229-33. PubMed ID: 15205579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational exposures and genetic susceptibility to urinary tract cancers: a systematic review and meta-analysis.
    Stojanovic J; Milovanovic S; Pastorino R; Iavicoli I; Boccia S
    Eur J Cancer Prev; 2018 Sep; 27(5):468-476. PubMed ID: 28403014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.